RNA Research Solutions
-   M2005 DMG-PEG2000-MALSummary: Maleimide-PEG derivatives, used for liposomal delivery M2005 DMG-PEG2000-MALSummary: Maleimide-PEG derivatives, used for liposomal delivery
-   B7953 Digoxigenin-11-UTPSummary: For transcription labeling of RNA probes used in in situ hybridization and other applications. B7953 Digoxigenin-11-UTPSummary: For transcription labeling of RNA probes used in in situ hybridization and other applications.
-   R1013 EZ Cap™ Firefly Luciferase mRNA (5-moUTP)15 CitationSummary: Firefly Luciferase mRNA with Cap 1 structure, modified by 5-moUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation. R1013 EZ Cap™ Firefly Luciferase mRNA (5-moUTP)15 CitationSummary: Firefly Luciferase mRNA with Cap 1 structure, modified by 5-moUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
-   K1063 HyperScribe™ All in One mRNA Synthesis Kit (ARCA, T7, poly(A))Summary: Used for the synthesis of ARCA capped and poly(A) tailed mRNA in vitro K1063 HyperScribe™ All in One mRNA Synthesis Kit (ARCA, T7, poly(A))Summary: Used for the synthesis of ARCA capped and poly(A) tailed mRNA in vitro
-   R1074 EZ Cap™ Mouse IL-36γ mRNA (m1Ψ, HA tag)Summary: Mouse IL-36γ mRNA with Cap 1 structure and HA tag sequence, modified by N1-Methylpseudo-UTP (m1Ψ), providing higher transcription efficiency and suppressing RNA-mediated innate immune activation. R1074 EZ Cap™ Mouse IL-36γ mRNA (m1Ψ, HA tag)Summary: Mouse IL-36γ mRNA with Cap 1 structure and HA tag sequence, modified by N1-Methylpseudo-UTP (m1Ψ), providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
-   R1037 EZ Cap™ Fdx1 mRNA (5-moUTP)Summary: Fdx1 mRNA with Cap 1 structure, modified by 5-moUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation. R1037 EZ Cap™ Fdx1 mRNA (5-moUTP)Summary: Fdx1 mRNA with Cap 1 structure, modified by 5-moUTP, providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
-   M2004 DMG-PEG2000-NHSSummary: NHS-PEG derivatives, used for liposomal delivery M2004 DMG-PEG2000-NHSSummary: NHS-PEG derivatives, used for liposomal delivery
-   R1012 Firefly Luciferase mRNA (ARCA, 5-moUTP)4 CitationSummary: Better performance of firefly luciferase mRNA modified by ARCA and 5-moUTP, inhibiting RNA-mediated innate immune activation, stable and efficient expression efficiency, used as an experimental control. R1012 Firefly Luciferase mRNA (ARCA, 5-moUTP)4 CitationSummary: Better performance of firefly luciferase mRNA modified by ARCA and 5-moUTP, inhibiting RNA-mediated innate immune activation, stable and efficient expression efficiency, used as an experimental control.
-   K1062 HyperScribe™ T7 High Yield Cy5 RNA Labeling KitSummary: Efficient T7 RNA In Vitro Transcription Kit with Cy3 Fluorescent Labeling K1062 HyperScribe™ T7 High Yield Cy5 RNA Labeling KitSummary: Efficient T7 RNA In Vitro Transcription Kit with Cy3 Fluorescent Labeling
-   R1071 EZ Cap™ Human IL-29 mRNA (m1Ψ, HA tag)Summary: Human IL-29 mRNA with Cap 1 structure and HA tag sequence, modified by N1-Methylpseudo-UTP (m1Ψ), providing higher transcription efficiency and suppressing RNA-mediated innate immune activation. R1071 EZ Cap™ Human IL-29 mRNA (m1Ψ, HA tag)Summary: Human IL-29 mRNA with Cap 1 structure and HA tag sequence, modified by N1-Methylpseudo-UTP (m1Ψ), providing higher transcription efficiency and suppressing RNA-mediated innate immune activation.
